Trial Profile
Efficacy and safety of pegylated liposomal doxorubicin in patients with advanced breast cancer
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Feb 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Feb 2015 New trial record